The investment strategy of the Company is to provide Shareholders with an attractive total return achieved primarily through capital growth. The Directors believe that there are numerous investment opportunities within the life sciences sector, globally.
The global focus on healthcare & wellbeing following the global Covid-19 pandemic provides significant opportunities across multiple sectors, including health & wellness, food & additives and medicines.
